TriCan Health

08/20/2026

Trican Health takes the stage Friday, August 21st from 3:45–5:30pm CDT at the Seena Magowitz Foundation's Power of Us Conference in Milwaukee.

We'll be busting common clinical trial myths, breaking down how trials actually work, and showing attendees how TriCan's trial finder makes searching simple. If you're there, come say hi!

Not able to join us in Milwaukee? Start your own trial search anytime → tricanhealth.com

08/17/2026

This Friday, our team is proud to speak at the Seena Magowitz Pancreatic Cancer Foundation's Power of Us Conference in Milwaukee. It'll be a weekend built for pancreatic cancer patients, survivors, and caregivers, and for learning all about clinical trials!

Our presentation will provide attendees with a practical guide to finding appropriate trials based on diagnosis, prior treatments, and any known biomarkers, enabling everyone to make informed treatment decisions using Trican's patient-friendly trial finder tool.

As 32-year survivor Kay Kays puts it, "Clinical trials should be your appetizer in your treatment, not your dessert." That's the mindset we hope more patients and families embrace, early and often.

Learn more about the conference → seenamagowitzfoundation.org

07/28/2026

Come join us in Milwaukee! TriCan Health will be presenting at the Seena Magowitz Pancreatic Cancer Foundation Power of Us conference in Milwaukee, Wisconsin August 21-23, 2026. We'll show survivors how to navigate clinical trials and access promising new medicines currently being evaluated for FDA approval.

Information: https://seenamagowitzfoundation.org/event/power-of-us-2026/

Registration: https://reg.eventmobi.com/power-of-us-2026/register

It's a wonderful opportunity for folks to connect with others who've shared their experience, learn about new treatments on the horizon, and get great information on nutrition and managing side effects.

06/24/2026

Register here (e2a0312a-b9b5-40a3-9709-d125ac70363c@a54392ec-492c-4907-95fe-e7eb2191a6e1)" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/e2a0312a-b9b5-40a3-9709-d125ac70363c@a54392ec-492c-4907-95fe-e7eb2191a6e1) for a free webinar Friday June 26th at 11am EDT with Sky Foundation, Inc. and TriCan Health on daraxonrasib, the breakthrough pancreatic cancer medication that got a standing ovation at ASCO.

TriCan Health will be moderating the discussion with two leading physicians/researchers at Karmanos Cancer Institute in Detroit, Dr. Azmi and Dr. Al-Hallak.

Pre-register now and please join us Friday morning for an informative discussion about a 'RAS inhibitor' that doubled the life expectancy of patients in a clinical trial. You can see the research publication here (https://www.nejm.org/doi/full/10.1056/NEJMoa2605555) for more details on the results of the trial.

06/08/2026

Great informational video (https://pie.med.utoronto.ca/TVASurg/project/pe-whipple-eng/ ) explaining the pancreas, forms of , and the Whipple surgical procedure, from the Toronto Video Atlas of Surgery - a great resource for patients and surgeons alike.

Helpfully, the video is available in English, French, Spanish and Turkish, as well. The site also has more detailed videos for surgeons on a wide variety of pancreatic surgeries.

Find that include surgery by searching on https://www.tricanhealth.com/ and indicating the tumor is resectable.

TriCan empowers cancer patients to advocate for their own treatment and gain access to the most advanced medicines available.

05/20/2026

Earlier this month, TriCan Health presented at the Pancreas Club meeting in Chicago. It was a great opportunity for pancreas surgeons and others in attendance to get access to a free platform to find best-match clinical trials for patients.

Many thanks to the Nikki Mitchell Foundation for the opportunity!

I had three key takeaways from the meeting:

1. RAS Inhibitors show incredible promise. The physicians in the audience were keenly focused on daraxonrasib and other drugs currently in trials (note - there are 42 (!) different trials in the US targeting RAS recruiting right now)

2. Personalization is king. Companies like Tempus AI provide genomic reports on the mutational burden within each tumor - so not just a binary measure of whether or not a biomarker is present, but to what extent. One pathologist presented research showing that two different tumors from a *single* origin site, metastasized in the *same* organ, might behave differently and therefore might benefit from individualized treatment. So not just personalized medicine per patient - personalized medicine *per tumor*. Amazing.

3. Organoids may help pinpoint effective therapies. An MD PhD at the meeting shared that cells taken from a tumor can be grown to ~1,000-cell organoids within about a week, and then those organoids can be used to select specific therapies, thereby avoiding resistance to typical standard of care adjuvant/neoadjuvant chemotherapies.

Incredible science continues to be conducted to address pancreatic cancer - many thanks to all the researchers and clinicians working every day to improve lives!

04/21/2026

Episode #5 of Clinical Trials Explained, hosted by Sky Foundation, Inc. and TriCan Health, is taking place tomorrow, Wednesday the 22nd at noon EDT! Register here: 2a3e164c-8aca-48ad-95c3-2573bfedb6cc@a54392ec-492c-4907-95fe-e7eb2191a6e1" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/2a3e164c-8aca-48ad-95c3-2573bfedb6cc@a54392ec-492c-4907-95fe-e7eb2191a6e1

Two long-time pancreatic cancer survivors will share their stories and how they approached clinical trials as a critical part of their informed decision for treatment options. Please register and join this free session!

04/06/2026

Register here (50cc191a-03c7-46a8-893f-4fd2842abb81@a54392ec-492c-4907-95fe-e7eb2191a6e1?blm_aid=11688960)" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/50cc191a-03c7-46a8-893f-4fd2842abb81@a54392ec-492c-4907-95fe-e7eb2191a6e1?blm_aid=11688960) for free webinar Episode #4 of the series Pancreatic Cancer Clinical Trials Explained, titled

Discovery & Enrollment

This session provides a practical, step-by-step guide for patients and caregivers navigating the clinical trial process, presented by Dr. Philip, Chair of Hematology/Oncology at Henry Ford Cancer Institute, and Laura Wood, RN, MSN, OCN at University of Michigan Cancer Center.

You’ll learn:

- What questions to ask your oncologist about clinical trials
- How eligibility criteria really works
- What documents and medical records you should have ready
- What to expect during screening and enrollment
- Why promising drugs cannot be offered outside of clinical trials
- How to prepare for conversations with trial site

Who should attend? Patients, caregivers, and family members actively exploring clinical trials or preparing for enrollment.

03/24/2026

Register here for a webinar hosted by Sky Foundation Inc. and TriCan Health on finding pancreatic cancer clinical trials. (e55ac7bd-1e2d-464e-ab2a-2c4e5bb14cab@a54392ec-492c-4907-95fe-e7eb2191a6e1?blm_aid=11688960)" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/e55ac7bd-1e2d-464e-ab2a-2c4e5bb14cab@a54392ec-492c-4907-95fe-e7eb2191a6e1?blm_aid=11688960)

This is Episode #3 in the series, focused on finding trials in Michigan (where Sky Foundation operates), designed to help patients and caregivers demystify clinical trials and receive practical advice on how to consider trials as treatment options.

Please join!

03/16/2026

Excellent resource for patients and caregivers battling pancreatic cancer. The Seena Magowitz Pancreatic Cancer Foundation is terrific, as is Steven Merlin, who's moderating the session.

13-Year pancreatic cancer survivor Steven Merlin hosts the Pancreatic Cancer Support for Survivorship Support Group Meeting on March 17th at 5:30pm Eastern time. Please join this live zoom meeting and speak directly with Steven Merlin, share information, and have your questions answered.

https://seenamagowitzfoundation.org/meeting/survivors-zoom-meeting-on-march-17th/